Project Grant HT94252510305
Award Date
9/30/25
Completion Date
9/29/28
Dollars Obligated
$483K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
The University of Florida's Division of Sponsored Research received a $718,988 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 3-year project aims to test a novel oxygen release therapeutic for the preservation of spinal cord tissue resulting from spinal cord injury ischemia. Key products and services to be delivered include: Obtaining IACUC and institutional safety approvals, purchasing equipment and animals,...
The University of Florida was awarded a $1,166,594 project grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "EARLY CARDIAC BIOMARKERS OF INFLAMMATION AND REMODELING IN DMD," will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The project will investigate innovative approaches to address critical health challenges related...
This federal Project Grant award, with a total funding amount of $381,276.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund research conducted by the University of Florida on the use of noninvasive vagus nerve stimulation to improve speech-in-noise perception in veterans with traumatic brain injury. The research aims to transform healthcare for military service members and the broader public by...
The University of Florida was awarded a $305,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop novel therapies for dystonia. Through this funding, the University of Florida Division of Sponsored Research will conduct research into medical solutions for dystonia that can potentially transform healthcare for service members and the...
The University of Florida was awarded a $5.796 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of September 1, 2023 through August 31, 2027. The grant will support the development of clinical candidates for the treatment of Myotonic Dystrophy at the University's location in Gainesville, Florida. As the prime awardee, the University will leverage its expertise in biomedical research to...
The University of Florida was awarded a $152,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2025, supports advanced biomedical research aimed at "Targeting TIE2 as a Novel Strategy in VEGFR Inhibitor-Resistant Angiosarcoma" with a performance period ending on July 31, 2027. The Military Medical Research and Development program funds a diverse portfolio of scientific...
The University of Florida was awarded a $304,894 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to develop localized oxygen delivery using silk fibroin-based micro-particles loaded with salmon hemoglobin from March 15, 2021 through March 14, 2023. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $4,182,053.00 to The Spaulding Rehabilitation Hospital Corporation to conduct a clinical trial titled "Breathing Low Oxygen to Enhance Spinal Stimulation Training and Functional Recovery for Aging Adults with Chronic SCI: The BO2ST-II Trial." The award period runs from Sep 30, 2024 to Sep 29, 2028. The project will investigate using low-oxygen...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $737,500.00 to Florida International University (FIU) to support a novel treatment for spinal cord injury-neuropathic pain by targeting fibroblast-derived PI16. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative medical solutions. FIU, a Hispanic-Serving Institution, will leverage its...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) in the amount of $1,765,321.00 was awarded to the University of Miami on September 30, 2023. The funding supports a four-year research project to develop functionalized peptide gels and utilize Schwann cells for repairing injured spinal cords. The University of Miami is the prime grantee and may collaborate with other research institutions as sub-grantees to execute...